Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Parke-Davis SAR studies lead to potent, selective D4 antagonist

April 28, 1997

Potent TNF inhibitor described by Celgene

April 28, 1997

Potential new treatments highlighted at recent periodontology symposium

April 28, 1997

Potent, metabolically stable cyclic urea HIV protease inhibitors under development at DuPont Merck

April 28, 1997

Glaxo Wellcome discovers potent BAT inhibitor

April 28, 1997

Potent, selective beta3-agonist from Merck & Co.

April 25, 1997

Amino-ketones from Roche found to lower cholesterol levels in animals

April 25, 1997

Novel marine antioxidant described by UNC researchers

April 25, 1997

Lilly prepares water-soluble echinocandin antifungal agents

April 25, 1997

Antiarthritic activity and mechanism of action of mercaptoethylguanidine

April 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....